OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.
By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.
BPC-157 5 mg + TB-500 5 mg. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Low reported | 500 mcg | 1× daily (250 mcg each) | 0.125 mL | 12.5 u | 20 doses | |
| Standard | 1000 mcg | 1× daily (500 mcg each) | 0.25 mL | 25 u | 10 doses | |
| Upper reported | 1500 mcg | 1× daily (750 mcg each) | 0.375 mL | 37.5 u | 6 doses |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial | |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 500 mcg | daily | 0.125 mL | 12.5 u | 14 | 7 mg |
| Weeks 3–4 | 1000 mcg | daily | 0.25 mL | 25 u | 14 | 14 mg |
| Week 5 onward per 4 weeks from here on |
1500 mcg | daily | 0.375 mL | 37.5 u | 28 | 42 mg |
The most common repair blend, equal parts BPC-157 and TB-500. Two sizes: the 10 mg vial holds 5 mg of each, the 20 mg vial holds 10 mg of each. The split is 50/50 either way, so every dose delivers half of it to each component regardless of which vial you have — a 1000 mcg dose is 500 mcg of each. The vial size changes how many doses you get, not the ratio. Switch the vial strength above to match what you are holding.
Buy Wolverine Blendthis peptideOpens optimal-pep.com in a new tab
Browse the full catalogue, or jump to a neighbouring compound.
The GLOW combination with KPV added. Same fixed-ratio constraint applies, with a fourth component narrowing the titration window f…
An equal-parts repair and anti-inflammatory pairing — 10 mg of each in a 20 mg vial, so every dose splits evenly down the middle a…
Every compound compared in one table: dose range, how often, half-life and evidence tier.